
-
Battling Forest see off Spurs to boost Champions League hopes
-
'I don't miss tennis' says Nadal
-
Biles 'not so sure' about competing at Los Angeles Olympics
-
Gang-ravaged Haiti nearing 'point of no return', UN warns
-
US assets slump again as Trump sharpens attack on Fed chief
-
Forest see off Spurs to boost Champions League hopes
-
Trump says Pope Francis 'loved the world,' will attend funeral
-
Oscar voters required to view all films before casting ballots
-
Bucks' Lillard upgraded to 'questionable' for game 2 v Pacers
-
Duplantis and Biles win Laureus World Sports Awards
-
US urges curb of Google's search dominance as AI looms
-
The Pope with 'two left feet' who loved the 'beautiful game'
-
With Pope Francis death, Trump loses top moral critic
-
Mourning Americans contrast Trump approach to late Pope Francis
-
Leeds and Burnley promoted to Premier League
-
Racist gunman jailed for life over US supermarket massacre
-
Trump backs Pentagon chief despite new Signal chat scandal
-
Macron vows to step up reconstruction in cyclone-hit Mayotte
-
Gill, Sudharsan help toppers Gujarat boss Kolkata in IPL
-
Messi, San Lorenzo bid farewell to football fan Pope Francis
-
Leeds on brink of Premier League promotion after smashing Stoke
-
In Lourdes, Catholic pilgrims mourn the 'pope of the poor'
-
Korir wins men's Boston Marathon, Lokedi upstages Obiri
-
China's CATL launches new EV sodium battery
-
Korir wins Boston Marathon, Lokedi upstages Obiri
-
Francis, a pope for the internet age
-
Iraq's top Shiite cleric says Pope Francis sought peace
-
Mourners flock to world's churches to grieve Pope Francis
-
Trump says Pope Francis 'loved the world'
-
Sri Lanka recalls Pope Francis' compassion on Easter bombing anniversary
-
Pope Francis inspired IOC president Bach to create refugee team
-
Alexander-Arnold will be remembered for 'good things' at Liverpool: Van Dijk
-
US VP Vance meets Indian PM Modi for tough talks on trade
-
Pentagon chief dismisses reports he shared military info with wife
-
15 potential successors to Pope Francis
-
The papabili - 15 potential successors to Pope Francis
-
Zhao sets up all-China clash after beating 2024 world snooker finalist Jones
-
Ostapenko stuns Sabalenka to win Stuttgart title
-
Argentina mourns loss of papal son
-
African leaders praise Pope Francis's 'legacy of compassion'
-
Mehidy's five wickets help Bangladesh fight back in first Zimbabwe Test
-
'The voice of god': Filipinos wrestle with death of Pope Francis
-
Prayers, disbelief in East Timor after Pope Francis death
-
Real Madrid hold minute's silence as La Liga mourns Pope Francis
-
World leaders pay tribute to Pope Francis, dead at 88
-
World leaders react to the death of Pope Francis
-
Zimbabwe lead first Test despite Bangladesh spinner Mehidy's five wickets
-
Vatican postpones sainthood for 'God's influencer' after pope's death
-
Pope's death prompts CONI to call for sporting postponements, minute's silence
-
Stunned and sad, faithful gather at St Peter's to remember Francis

US panel weighs authorizing Covid vaccines for youngest children
After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.
Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.
Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."
Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.
Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.
They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.
Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.
But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.
There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.
White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.
Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.
Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.
Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.
Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."
E.Schubert--BTB